A national perspective on the management of high-risk BCG-unresponsive non-muscle-invasive bladder cancer in Romania
Though RC remains the predominant approach for BCG-unresponsive cases, over half of urologists' report using intravesical chemotherapy, reflecting interest in bladder-sparing strategies rather than newly approved FDA agents.
Authors
- Mohamad Abou Chakra (ORCID: https://orcid.org/0000-0002-4293-3314)
- Bogdan Adrian Buhaş (ORCID: https://orcid.org/0000-0002-5981-3802)
- Maximilian Buzoianu
- Mihnea Bogdan Borz
- Emanuela Maria Ionutas
- Nicolae Crisan
- Michael A O'Donnell
Institutions
- Iuliu Hațieganu University of Medicine and Pharmacy (RO)
- Universitatea de Medicină, Farmacie, Științe și Tehnologie „George Emil Palade” din Târgu Mureș (RO)
- Spitalul Clinic CF Cluj-Napoca (RO)
- University of Iowa Health Care (US)
Publication Details
- Journal
- Archivio Italiano di Urologia e Andrologia
- Published
- 2025-12-24
- DOI
- https://doi.org/10.4081/aiua.2025.14596
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00